Select Medical Holdings Corp
SEM13.440USD
+0.080+0.60%
Cierre 11/11, 16:00（ET）Cotizaciones retrasadas 15 min
1.66BCap. mercado
14.61P/E TTM
Más Datos de Select Medical Holdings Corp Compañía
Select Medical Holdings Corporation is an operator of critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation clinics in the United States. The Company’s segments include the critical illness recovery hospital, the rehabilitation hospital, and the outpatient rehabilitation. Its critical illness recovery hospital segment consists of hospitals designed to serve the needs of patients recovering from critical illnesses, often with complex medical needs, and its rehabilitation hospital segment consists of hospitals designed to serve patients that require intensive physical rehabilitation care. Its outpatient rehabilitation segment consists of clinics that provide physical, occupational, and speech rehabilitation services. The Company operates about 106 critical illness recovery hospitals in 29 states, 34 rehabilitation hospitals in 13 states, and 1,925 outpatient rehabilitation clinics in 39 states and the District of Columbia.
Información de Select Medical Holdings Corp
Símbolo de cotizaciónSEM
Nombre de la empresaSelect Medical Holdings Corp
Fecha de salida a bolsaSep 25, 2009
Director ejecutivoMr. David S. Chernow
Número de empleados30000
Tipo de seguridadOrdinary Share
Fin del año fiscalSep 25
DirecciónC/O Select Medical Corp
CiudadMECHANICSBURG
Bolsa de valoresNYSE Consolidated
PaísUnited States of America
Código postal17055
Teléfono17179721100
Sitio Webhttps://www.selectmedical.com/
Símbolo de cotizaciónSEM
Fecha de salida a bolsaSep 25, 2009
Director ejecutivoMr. David S. Chernow
Ejecutivos de Select Medical Holdings Corp
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Robert A. Ortenzio
Mr. Robert A. Ortenzio
Executive Chairman of the Board, Co-Founder
Executive Chairman of the Board, Co-Founder
9.20M
+2.79%
Mr. Martin F. Jackson
Mr. Martin F. Jackson
Senior Executive Vice President of Strategic Finance and Operations
Senior Executive Vice President of Strategic Finance and Operations
1.39M
-2.07%
Mr. David S. Chernow
Mr. David S. Chernow
Vice Chairman of the Board
Vice Chairman of the Board
892.83K
-5.21%
Mr. Russell L. Carson
Mr. Russell L. Carson
Lead Independent Director
Lead Independent Director
610.03K
+2.35%
Mr. Thomas P. (Tom) Mullin
Mr. Thomas P. (Tom) Mullin
Chief Executive Officer
Chief Executive Officer
391.71K
-5.33%
Mr. Brian R. Rusignuolo
Mr. Brian R. Rusignuolo
Executive Vice President, Chief Information Officer
Executive Vice President, Chief Information Officer
361.37K
-3.90%
Mr. Michael F. Malatesta
Mr. Michael F. Malatesta
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
238.06K
-3.00%
Mr. Thomas A. (Tom) Scully, J.D.
Mr. Thomas A. (Tom) Scully, J.D.
Independent Director
Independent Director
89.39K
+12.60%
Dr. Parvinderjit Singh Khanuja
Dr. Parvinderjit Singh Khanuja
Independent Director
Independent Director
79.12K
+21.56%
Ms. Katherine R. Davisson
Ms. Katherine R. Davisson
Independent Director
Independent Director
60.03K
+30.51%
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Robert A. Ortenzio
Mr. Robert A. Ortenzio
Executive Chairman of the Board, Co-Founder
Executive Chairman of the Board, Co-Founder
9.20M
+2.79%
Mr. Martin F. Jackson
Mr. Martin F. Jackson
Senior Executive Vice President of Strategic Finance and Operations
Senior Executive Vice President of Strategic Finance and Operations
1.39M
-2.07%
Mr. David S. Chernow
Mr. David S. Chernow
Vice Chairman of the Board
Vice Chairman of the Board
892.83K
-5.21%
Mr. Russell L. Carson
Mr. Russell L. Carson
Lead Independent Director
Lead Independent Director
610.03K
+2.35%
Mr. Thomas P. (Tom) Mullin
Mr. Thomas P. (Tom) Mullin
Chief Executive Officer
Chief Executive Officer
391.71K
-5.33%
Mr. Brian R. Rusignuolo
Mr. Brian R. Rusignuolo
Executive Vice President, Chief Information Officer
Executive Vice President, Chief Information Officer
361.37K
-3.90%
Desglose de ingresos
Divisa: USDActualizado: lun., 6 de oct
Divisa: USDActualizado: lun., 6 de oct
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Por negocioUSD
Nombre
Ganancia
Proporción
Non-Medicar
826.30M
61.68%
Medicare
381.56M
28.48%
Other
97.08M
7.25%
Other revenues
34.64M
2.59%
Sin datos
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Non-Medicar
826.30M
61.68%
Medicare
381.56M
28.48%
Other
97.08M
7.25%
Other revenues
34.64M
2.59%
Estadísticas de accionistas
Actualizado: sáb., 16 de ago
Actualizado: sáb., 16 de ago
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
T. Rowe Price Associates, Inc.
12.94%
BlackRock Institutional Trust Company, N.A.
12.92%
The Vanguard Group, Inc.
10.13%
Ortenzio (Robert A)
7.43%
Dimensional Fund Advisors, L.P.
4.03%
Otro
52.55%
Accionistas
Accionistas
Proporción
T. Rowe Price Associates, Inc.
12.94%
BlackRock Institutional Trust Company, N.A.
12.92%
The Vanguard Group, Inc.
10.13%
Ortenzio (Robert A)
7.43%
Dimensional Fund Advisors, L.P.
4.03%
Otro
52.55%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
53.73%
Investment Advisor/Hedge Fund
20.38%
Individual Investor
15.52%
Research Firm
3.02%
Hedge Fund
2.64%
Pension Fund
1.14%
Bank and Trust
0.53%
Sovereign Wealth Fund
0.19%
Insurance Company
0.03%
Otro
2.82%
Participación institucional
Actualizado: mié., 1 de oct
Actualizado: mié., 1 de oct
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q3
584
101.41M
81.89%
-13.28M
2025Q2
593
128.59M
103.28%
-15.30M
2025Q1
613
130.41M
101.46%
-13.79M
2024Q4
596
127.65M
98.98%
-7.70M
2024Q3
574
125.33M
96.47%
-2.82M
2024Q2
559
125.84M
96.80%
-1.37M
2024Q1
555
124.62M
97.09%
-1.67M
2023Q4
554
125.18M
97.72%
-2.54M
2023Q3
563
124.92M
98.22%
-6.02M
2023Q2
572
126.44M
99.43%
-8.51M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
T. Rowe Price Associates, Inc.
16.02M
12.92%
-1.05M
-6.17%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
15.99M
12.9%
-497.15K
-3.01%
Jun 30, 2025
The Vanguard Group, Inc.
12.90M
10.4%
-377.96K
-2.85%
Jun 30, 2025
Ortenzio (Robert A)
9.20M
7.42%
+250.00K
+2.79%
Jul 29, 2025
Dimensional Fund Advisors, L.P.
4.99M
4.02%
+773.73K
+18.35%
Jun 30, 2025
State Street Investment Management (US)
4.25M
3.43%
+55.69K
+1.33%
Jun 30, 2025
Rocco A. Ortenzio UEO
4.09M
3.3%
-3.80M
-48.22%
Dec 31, 2024
T. Rowe Price Investment Management, Inc.
3.60M
2.9%
-429.17K
-10.65%
Jun 30, 2025
Geode Capital Management, L.L.C.
3.04M
2.45%
+80.42K
+2.72%
Jun 30, 2025
Principal Global Investors (Equity)
2.92M
2.36%
+447.99K
+18.09%
Jun 30, 2025
Ver más
ETFs relacionados
Actualizado: jue., 6 de nov
Actualizado: jue., 6 de nov
Nombre
Proporción
SPDR S&P Health Care Services ETF
1.96%
Invesco S&P SmallCap Health Care ETF
0.9%
Invesco S&P SmallCap Value with Momentum ETF
0.8%
Invesco S&P SmallCap High Dividend Low Volatility ETF
0.71%
WisdomTree US SmallCap Quality Dividend Growth
0.65%
Invesco S&P SmallCap 600 Pure Value ETF
0.62%
Invesco S&P SmallCap 600 Revenue ETF
0.44%
Invesco S&P SmallCap Quality ETF
0.4%
iShares US Small Cap Value Factor ETF
0.39%
First Trust Small Cap Value AlphaDEX Fund
0.38%
Ver más
SPDR S&P Health Care Services ETF
Proporción1.96%
Invesco S&P SmallCap Health Care ETF
Proporción0.9%
Invesco S&P SmallCap Value with Momentum ETF
Proporción0.8%
Invesco S&P SmallCap High Dividend Low Volatility ETF
Proporción0.71%
WisdomTree US SmallCap Quality Dividend Growth
Proporción0.65%
Invesco S&P SmallCap 600 Pure Value ETF
Proporción0.62%
Invesco S&P SmallCap 600 Revenue ETF
Proporción0.44%
Invesco S&P SmallCap Quality ETF
Proporción0.4%
iShares US Small Cap Value Factor ETF
Proporción0.39%
First Trust Small Cap Value AlphaDEX Fund
Proporción0.38%
Dividendos
Un total de
243.71M
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Feb 20, 2025
SEM.NB Interim Cash Dividend of gross USD 0.0625 paid on Mar 13, 2025 going ex on Mar 03, 2025
Mar 03, 2025
Mar 13, 2025
Mar 03, 2025
Oct 31, 2024
SEM.NB Final Cash Dividend of gross USD 0.125 paid on Nov 26, 2024 going ex on Nov 13, 2024
Nov 13, 2024
Nov 26, 2024
Nov 13, 2024
Aug 01, 2024
SEM.NB Interim Cash Dividend of gross USD 0.125 paid on Aug 30, 2024 going ex on Aug 14, 2024
Aug 14, 2024
Aug 30, 2024
Aug 14, 2024
May 02, 2024
SEM.NB Interim Cash Dividend of gross USD 0.125 paid on May 30, 2024 going ex on May 15, 2024
May 16, 2024
May 30, 2024
May 15, 2024
Feb 22, 2024
SEM.NB Interim Cash Dividend of gross USD 0.125 paid on Mar 13, 2024 going ex on Feb 29, 2024
Mar 01, 2024
Mar 13, 2024
Feb 29, 2024
Nov 02, 2023
SEM.NB Final Cash Dividend of gross USD 0.125 paid on Nov 28, 2023 going ex on Nov 14, 2023
Nov 15, 2023
Nov 28, 2023
Nov 14, 2023
Aug 03, 2023
SEM.NB Interim Cash Dividend of gross USD 0.125 paid on Sep 01, 2023 going ex on Aug 14, 2023
Aug 15, 2023
Sep 01, 2023
Aug 14, 2023
May 04, 2023
SEM.NB Interim Cash Dividend of gross USD 0.125 paid on May 31, 2023 going ex on May 17, 2023
May 18, 2023
May 31, 2023
May 17, 2023
Feb 23, 2023
SEM.NB Interim Cash Dividend of gross USD 0.125 paid on Mar 15, 2023 going ex on Mar 02, 2023
Mar 03, 2023
Mar 15, 2023
Mar 02, 2023
Nov 03, 2022
SEM.NB Final Cash Dividend of gross USD 0.125 paid on Nov 29, 2022 going ex on Nov 15, 2022
Nov 16, 2022
Nov 29, 2022
Nov 15, 2022
Ver más
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
